Understanding the Requirements of Direct to Patient Trials (WS7)
- Date:
- 24 April 2017
- Time:
- -
- Available Seats:
- 35
Ensuring safety and quality are maintained when direct to patient clinical supplies distribution occurs remains a major Supply Chain concern. Dynamic enrollment, aggressive recruitment, confidentiality and drug supply/ cost are driving the industry to find alternative ways to supply IMP closer to the patient. This workshop will provide a forum for discussing ideas and solutions to the overcome/ prevent issues with direct shipments to patients.
